JPRN-UMIN000037258招募中Unknown
Real world assessment for Sofosbuvir + Velpatasvir therapy for decompensated cirrhotic patients with HCV - Sofvel study-1
Osaka City University Graduate School of Medicine0 个研究点目标入组 25 人开始时间: 2024年3月31日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Active Hepatocelluar Carcinoma Renal impairment; eGFR <30ml/min/1.73m2 Allergy to Sofosbuvir or Velpatasvir
研究者
相似试验
招募中
Unknown
Efficacy and Safety of sofosbuvir/velpatasvir for HCV infected patients with decompensated LCJPRN-UMIN000050343Hokkaido University Hospital50
招募中
不适用
Evaluation of the efficacy of sofosbuvir and velpatasvir in HCV-infected Japanese patients with decompensated cirrhosis: a prospective study in real life settings.decompensated cirrhotic patients with hepatitis C virusJPRN-UMIN000035711Toranomon Hospital100
招募中
不适用
Evaluation of the efficacy of sofosbuvir/velpatasvir and ribavirin in Japanese hepatitis C patients who failed direct-acting antiviral agents: a prospective study in real life settings.cirrhotic and non cirrhotic patients with hepatitis C virusJPRN-UMIN000035713Toranomon Hospital150
已完成
不适用
Prospective study of Sofosbuvir and Ledipasvir for HCV genotype 1 infected Japanese patientsGenotype 1 infected chronic liver diseasesJPRN-UMIN000019400Osaka City University and affiliated hospitals400
已完成
不适用
Efficacy and safety of sofosbuvir/belpatasvir combination tablets for patients infected with pan-genotypic hepatitis C virusChronic liver disease infected with HCVJPRN-UMIN000035625Saitama Medical University35